Hadasit Bio (Israel) Profile

501.10
ILS 7.8  1.53%
85%
55%

Hadasit Bio Summary

Hadasit Bio Holdings Ltd (HDST) is traded on Tel Aviv Stock Exchange in Israel. It is located in Jerusalem Bio-Park and employs 5 people. The company currently falls under 'Micro-Cap' category with current market capitalization of 51.55 M. Hadasit Bio Holdings Ltd has 11.05 M outstanding shares. HADASIT BIO HLDGS has accumulated about 54.71 M in cash with (17.57 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.96.
Check Hadasit Bio Probability Of Bankruptcy

Hadasit Bio Target Price Odds Analysis

Odds Below 501.1HorizonTargetOdds Above 501.1
88.82%30 days 501.10 11.00%
Based on normal probability distribution, the odds of Hadasit Bio to move above current price in 30 days from now is about 11.0% (This Hadasit Bio Holdings Ltd probability density function shows the probability of Hadasit Bio Stock to fall within a particular range of prices over 30 days) .

Hadasit Bio Holdings Risk Profiles

Hadasit Bio Key Fundamentals

Hadasit Bio Against Markets

Hadasit Bio Current Ratings

Hadasit Bio Holdings Ltd 30 Days Performance Scores

Risk Adjusted
Performance Score (0 to 100)
5 
Chance of
Financial Distress (0 to 100%)
2 
Equity ratings for Hadasit Bio Holdings Ltd are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
Hadasit Bio-Holdings, Ltd., through its subsidiaries, engages in the research and development in medical and biotechnology fields in Israel. Hadasit Bio-Holdings, Ltd. was founded in 2005 and is based in Jerusalem, Israel. Hadasit Bio operates under Biotechnology classification in Israel and traded on Tel Aviv Stock Exchange. more
NameHadasit Bio Holdings Ltd
CEOMichel HabibView All
Macroaxis Advice
InstrumentIsrael Stock View All
Business AddressJerusalem Bio-Park
Foreign Associate  USA
ExchangeTel Aviv Stock Exchange
SectorHealthcare
BenchmarkDOW
Websitewww.hbl.co.il
Phone972 2 677 8757
CurrencyILS - Israeli Shekel

Did you try this?

Run Portfolio Reporting Now

   

Portfolio Reporting

Create custom reports across your portfolios and generate quick suggestion pitch
All  Next Launch Portfolio Reporting

Hadasit Bio Directors

Hadasit Bio Corporate Directors

Yaakov Naparstek Director
Yigal Erlich Director
Merav Kaye Director
Please also check Risk vs Return Analysis. Please also try Equity Analysis module to research over 250,000 global equities including funds, stocks and etfs to find investment opportunities.
Search macroaxis.com